|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date01 Jul 1959 |
100 Clinical Results associated with LifSa Pharma
0 Patents (Medical) associated with LifSa Pharma
100 Deals associated with LifSa Pharma
100 Translational Medicine associated with LifSa Pharma